Urogen Pharma - Stock Price History | URGN

Historical daily share price chart and data for Urogen Pharma since 2021 adjusted for splits. The latest closing stock price for Urogen Pharma as of October 22, 2021 is 17.08.
  • The all-time high Urogen Pharma stock closing price was 65.33 on May 18, 2018.
  • The Urogen Pharma 52-week high stock price is 28.20, which is 65.1% above the current share price.
  • The Urogen Pharma 52-week low stock price is 14.19, which is 16.9% below the current share price.
  • The average Urogen Pharma stock price for the last 52 weeks is 18.70.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Urogen Pharma Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 23.7342 32.5700 34.6000 13.6800 18.0200 -46.00%
2019 34.5999 44.5100 54.5500 21.1100 33.3700 -22.50%
2018 49.9612 38.6400 65.3300 38.3500 43.0600 15.72%
2017 26.0245 13.9800 43.2600 13.9800 37.2100 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.000B $0.012B
UroGen Pharma Ltd. is a clinical stage biopharmaceutical company. It focused on developing urological pathologies with a focus on uro-oncology. The company's product candidates include MitoGel and VesiGel which are in clinical trial stage. Its platform technologies include: RTGel and Immunotherapy. UroGen Pharma Ltd. is based in Ra'anana, Israel.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76